AskBio has an adeno-associated virus (AAV)-based gene therapy platform and has been driving Bayer’s pipeline of gene therapies that are developed across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications. Most advanced in the clinic are investigational treatments for Parkinson’s disease, Pompe disease and congestive heart failure.
